All Relations between cannabis and cannabinoids

Publication Sentence Publish Date Extraction Date Species
Jami D Reber, Erin L Karschner, Joshua Z Seither, Jessica L Knittel, Katherine V Dozier, Jeffrey P Walterschei. An Enhanced LC-MS/MS Technique for Distinguishing Δ8- and Δ9-Tetrahydrocannabinol Isomers in Blood and Urine Specimens. Journal of analytical toxicology. 2022-03-10. PMID:35265983. among the abundance of cannabinoids identified in cannabis, the active parent drug, Δ9-tetrahydrocannabinol (Δ9-thc), and its oxidized metabolite, 11-nor-9-carboxy-Δ9-thc (Δ9-thccooh), are attractive analytical targets to detect cannabis use. 2022-03-10 2023-08-13 Not clear
Eve M O'Reilly, Joanne M Cosgrave, William M Gallagher, Antoinette S Perr. Plant-derived cannabinoids as anticancer agents. Trends in cancer. 2022-03-09. PMID:35260379. substantial preclinical evidence demonstrates the antiproliferative, cytotoxic, and antimetastatic properties of plant-derived cannabinoids (phytocannabinoids) such as cannabidiol and tetrahydrocannabinol. 2022-03-09 2023-08-13 Not clear
Svante Vikingsson, Ruth E Winecker, Edward J Cone, David J Kuntz, Brian Dorsey, Martin Jacques, Melanie Senter, Ronald R Flegel, Eugene D Haye. Prevalence of Cannabidiol, Δ9- and Δ8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens. Journal of analytical toxicology. 2022-03-09. PMID:35260906. given the recent popularity of cannabidiol (cbd) use and the emergence of Δ8-tetrahydrocannabinol (Δ8-thc), the prevalence and concentration of these and other cannabinoids was investigated in 2,000 regulated and 4,000 non-regulated specimens from workplace drug testing. 2022-03-09 2023-08-13 Not clear
Svante Vikingsson, Ruth E Winecker, Edward J Cone, David J Kuntz, Brian Dorsey, Martin Jacques, Melanie Senter, Ronald R Flegel, Eugene D Haye. Prevalence of Cannabidiol, Δ9- and Δ8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens. Journal of analytical toxicology. 2022-03-09. PMID:35260906. parent Δ8-thc is a minor cannabinoid in marijuana, which appears to account for the typically low Δ8-thc-cooh concentrations (median 3.4 ng/ml) in most positive specimens. 2022-03-09 2023-08-13 Not clear
Caroline Figueira Pereira, Divane de Vargas, Fernanda Lima Toneloto, Victor Daichi Ito, Rosa Jacinto Volpat. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review. Revista brasileira de enfermagem. vol 75Suppl 1. issue Suppl 1. 2022-03-09. PMID:35262598. implications of cannabis and cannabinoid use in covid-19: scoping review. 2022-03-09 2023-08-13 Not clear
Caroline Figueira Pereira, Divane de Vargas, Fernanda Lima Toneloto, Victor Daichi Ito, Rosa Jacinto Volpat. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review. Revista brasileira de enfermagem. vol 75Suppl 1. issue Suppl 1. 2022-03-09. PMID:35262598. to identify and synthesize studies on the effects of cannabis use and its relation with sars-cov-2, as well as the therapeutic possibilities of using cannabinoids in the prevention and treatment of covid-19. 2022-03-09 2023-08-13 Not clear
Adeyinka Adeniyi, Sandra Abadir, Mohammed Kooshkabadi, Sunday O Yusuf, Radhika Khanna, Biagio Collura, Marie Anais Hichar. Recreational Marijuana Use and Coronary Artery Dissection: A Case Series. Cureus. vol 14. issue 1. 2022-03-07. PMID:35251848. adverse cardiovascular consequences of recreational use of marijuana and synthetic cannabinoids include stroke, artery dissection, vasospasm, vasculitis, coronary artery thrombosis, myocarditis/pericarditis, postural hypotension, arrhythmias, and acute heart failure. 2022-03-07 2023-08-13 Not clear
Kara Amstutz, Wayne S Schwark, Alexander Zakharov, Beatriz Gomez, Alex Lyubimov, Karolynn Ellis, Kurt P Venator, Joseph J Wakshla. Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation. Journal of veterinary pharmacology and therapeutics. 2022-03-05. PMID:35246858. the use of cannabinoids in veterinary medicine has been increasing exponentially recently and there is little information regarding the pharmacokinetics of cannabinoids except for cannabidiol (cbd) and tetrahydrocannabinol (thc), with even more sparse information related to their native acid forms found in cannabis. 2022-03-05 2023-08-13 Not clear
Kara Amstutz, Wayne S Schwark, Alexander Zakharov, Beatriz Gomez, Alex Lyubimov, Karolynn Ellis, Kurt P Venator, Joseph J Wakshla. Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation. Journal of veterinary pharmacology and therapeutics. 2022-03-05. PMID:35246858. cannabigerol (cbg) is the precursor molecule to cannabinoid formation in the cannabis plant which may have medicinal properties as well, yet there are no publications related to cbg or the native cannabigerolic acid (cbga) in companion animal species. 2022-03-05 2023-08-13 Not clear
Nikolaos Garmpis, Christos Damaskos, Dimitrios Dimitroulis, Anna Garmpi, Evangelos Diamantis, Panagiotis Sarantis, Vasiliki E Georgakopoulou, Alexandros Patsouras, Dionysios Prevezanos, Athanasios Syllaios, Georgios Kyriakos, Evangelos Koustas, Markos Despotidis, Christos Vallilas, Petros Papalexis, Efstathios A Antoniou, Konstantinos Kontzoglou, Gregory Kourakli. Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer? In vivo (Athens, Greece). vol 36. issue 2. 2022-03-04. PMID:35241505. cannabinoids, the active components of cannabis sativa l., and their derivatives, have been reported as palliative adjuvants to conventional chemotherapeutic regimens. 2022-03-04 2023-08-13 Not clear
Daniele Piomelli, Robert Solomon, Donald Abrams, Agnes Balla, Igor Grant, Thomas Marcotte, John Yode. Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward. Cannabis and cannabinoid research. vol 4. issue 1. 2022-03-03. PMID:35236017. regulatory barriers to research on cannabis and cannabinoids: a proposed path forward. 2022-03-03 2023-08-13 Not clear
Alexander Jordan, Ali Sherazi, Andrew J Flewelling, Victoria Northrup, Ather Naseemuddin, Jennifer L She. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization. The International journal on drug policy. vol 103. 2022-03-01. PMID:35228057. identification of cannabinoids in post-mortem blood samples from the province of new brunswick before and after recreational cannabis legalization. 2022-03-01 2023-08-13 Not clear
Alexander Jordan, Ali Sherazi, Andrew J Flewelling, Victoria Northrup, Ather Naseemuddin, Jennifer L She. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization. The International journal on drug policy. vol 103. 2022-03-01. PMID:35228057. given the immediate availability of cannabis in nb after legalization, we sought to establish the effect this had on post-mortem cannabinoid detection. 2022-03-01 2023-08-13 Not clear
Sara Casati, Ilaria Angeli, Roberta F Bergamaschi, Alessandro Ravelli, Gaia Colombo, Giorgio Binelli, Mauro Minoli, Marica Oriol. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use. Forensic science international. vol 333. 2022-03-01. PMID:35228140. determination of cannabinoids in hair: indicators for illegal vs cbd-rich cannabis use. 2022-03-01 2023-08-13 Not clear
Sara Casati, Ilaria Angeli, Roberta F Bergamaschi, Alessandro Ravelli, Gaia Colombo, Giorgio Binelli, Mauro Minoli, Marica Oriol. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use. Forensic science international. vol 333. 2022-03-01. PMID:35228140. in this paper, which aims to establish alternative discrimination parameters between hair samples from cbd-rich and thc-prevalent cannabis users, cannabinoid concentrations, such as thc, cbd, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (thc-cooh) and 11-hydroxy-Δ9-tetrahydrocannabinol (11-oh-thc) were quantified in 127 hair samples by a gc-ms/ms technique. 2022-03-01 2023-08-13 Not clear
Jaime M Monti, Seithikurippu R Pandi-Peruma. Clinical Management of Sleep and Sleep Disorders With Cannabis and Cannabinoids: Implications to Practicing Psychiatrists. Clinical neuropharmacology. 2022-02-28. PMID:35221321. clinical management of sleep and sleep disorders with cannabis and cannabinoids: implications to practicing psychiatrists. 2022-02-28 2023-08-13 Not clear
Ali E Dabiri, Ghassan S Kassa. Effects of Cannabis on Cardiovascular System: The Good, the Bad, and the Many Unknowns. Medical cannabis and cannabinoids. vol 4. issue 2. 2022-02-28. PMID:35224427. the purpose of this review was to provide an overview of the known medicinal benefits of selected cannabis cannabinoids and the known side effects or contraindications. 2022-02-28 2023-08-13 Not clear
Kaleb Bogale, Wesley Raup-Konsavage, Shannon Dalessio, Kent Vrana, Matthew D Coate. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. Medical cannabis and cannabinoids. vol 4. issue 2. 2022-02-28. PMID:35224429. similarly, a growing number of animal and human studies have been undertaken to evaluate the impact of cannabis and cannabinoid signaling elements on the natural history of ibd and its associated complications. 2022-02-28 2023-08-13 human
Kaleb Bogale, Wesley Raup-Konsavage, Shannon Dalessio, Kent Vrana, Matthew D Coate. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. Medical cannabis and cannabinoids. vol 4. issue 2. 2022-02-28. PMID:35224429. in this review, we discuss the role of cannabis and cannabinoid signaling in visceral pain perception, what is currently known regarding the efficacy of cannabis and its derivatives for managing pain, related symptoms and inflammation in ibd, and what work remains to effectively utilize cannabis and its derivatives in the clinical setting. 2022-02-28 2023-08-13 human
Holly Mansell, Declan Quinn, Lauren E Kelly, Jane Alcor. Cannabis for the Treatment of Attention Deficit Hyperactivity Disorder: A Report of 3 Cases. Medical cannabis and cannabinoids. vol 5. issue 1. 2022-02-28. PMID:35224434. blood samples were also collected from the patients to determine the plasma concentrations of the cannabinoids and relevant metabolites before and after a cannabis administration. 2022-02-28 2023-08-13 Not clear